Literature DB >> 26126778

Treating Hypertension in Pregnancy.

Dietmar Schlembach1, Volker Homuth, Ralf Dechend.   

Abstract

Hypertension is present in about 10 % of all pregnancies. The frequency of chronic hypertension and that of gestational hypertension is increasing. The management of pregnant women with hypertension remains a significant, but controversial, public health problem. Although treatment of hypertension in pregnancy has shown to reduce maternal target organ damage, considerable debate remains concerning treatment. We review current evidence regarding treatment goals, the ideal treatment starting time, and which drugs are available for the treatment of hypertension in pregnancy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26126778     DOI: 10.1007/s11906-015-0572-y

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  56 in total

1.  Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials.

Authors:  L A Magee; E Elran; S B Bull; A Logan; G Koren
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2000-01       Impact factor: 2.435

2.  Lactation and maternal subclinical cardiovascular disease among premenopausal women.

Authors:  Candace K McClure; Janet M Catov; Roberta B Ness; Eleanor Bimla Schwarz
Journal:  Am J Obstet Gynecol       Date:  2012-05-02       Impact factor: 8.661

3.  Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil.

Authors:  Juergen R Wacker; Barbara K Wagner; Volker Briese; Burkhard Schauf; Lothar Heilmann; Clemens Bartz; Hartmut Hopp
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-10-25       Impact factor: 2.435

4.  Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia.

Authors: 
Journal:  Obstet Gynecol       Date:  2011-12       Impact factor: 7.661

5.  Overview of randomised trials of diuretics in pregnancy.

Authors:  R Collins; S Yusuf; R Peto
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-05

6.  Effect of antihypertensive therapy with alpha-methyldopa on uterine artery Doppler in pregnancies with hypertensive disorders.

Authors:  A Khalil; K Harrington; S Muttukrishna; E Jauniaux
Journal:  Ultrasound Obstet Gynecol       Date:  2010-06       Impact factor: 7.299

7.  Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure.

Authors:  James N Martin; Brad D Thigpen; Robert C Moore; Carl H Rose; Julie Cushman; Warren May
Journal:  Obstet Gynecol       Date:  2005-02       Impact factor: 7.661

Review 8.  How to manage hypertension in pregnancy effectively.

Authors:  Laura A Magee; Edgardo Abalos; Peter von Dadelszen; Baha Sibai; Tom Easterling; Steve Walkinshaw
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

9.  Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom.

Authors:  Roch Cantwell; Thomas Clutton-Brock; Griselda Cooper; Andrew Dawson; James Drife; Debbie Garrod; Ann Harper; Diana Hulbert; Sebastian Lucas; John McClure; Harry Millward-Sadler; James Neilson; Catherine Nelson-Piercy; Jane Norman; Colm O'Herlihy; Margaret Oates; Judy Shakespeare; Michael de Swiet; Catherine Williamson; Valerie Beale; Marian Knight; Christopher Lennox; Alison Miller; Dharmishta Parmar; Jane Rogers; Anna Springett
Journal:  BJOG       Date:  2011-03       Impact factor: 6.531

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  1 in total

1.  Dwarfism and insulin resistance in male offspring caused by α1-adrenergic antagonism during pregnancy.

Authors:  Rebecca Oelkrug; Beate Herrmann; Cathleen Geissler; Lisbeth Harder; Christiane Koch; Hendrik Lehnert; Henrik Oster; Henriette Kirchner; Jens Mittag
Journal:  Mol Metab       Date:  2017-07-01       Impact factor: 7.422

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.